It was found that the risk score had negative correlation with the BTLA, CD27, CD40, CD80, and TNFRSF14 expression, which had significant differences in different risk groups (Supplementary Figure S2), indicating that tumor immunosuppression might lead to an increased risk score of patients. This evidence concerns the gene CD80 and neoplasm.